Immunological and clinical correlation in patients with rheumatoid arthritis associated with autoimmune thyroiditis
- Авторлар: Dvorovkin A.E1, Odin V.I1, Inamova O.V2, Tyrenko V.V1, Toporkov M.M1, Tzygan E.N1
-
Мекемелер:
- S.M. Kirov Military Medical Academy
- Rheumatic Clinical Hospital № 25
- Шығарылым: Том 11, № 3 (2016)
- Беттер: 144-149
- Бөлім: Articles
- ##submission.dateSubmitted##: 05.01.2023
- ##submission.datePublished##: 15.09.2016
- URL: https://genescells.ru/2313-1829/article/view/120614
- DOI: https://doi.org/10.23868/gc120614
- ID: 120614
Дәйексөз келтіру
Аннотация
Толық мәтін
![Рұқсат жабық](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
A. Dvorovkin
S.M. Kirov Military Medical AcademySaint Petersburg, Russia
V. Odin
S.M. Kirov Military Medical AcademySaint Petersburg, Russia
O. Inamova
Rheumatic Clinical Hospital № 25Saint Petersburg, Russia
V. Tyrenko
S.M. Kirov Military Medical AcademySaint Petersburg, Russia
M. Toporkov
S.M. Kirov Military Medical AcademySaint Petersburg, Russia
E. Tzygan
S.M. Kirov Military Medical AcademySaint Petersburg, Russia
Әдебиет тізімі
- Насонов Е.Л. Ревматоидный артрит. В: Насонов Е.Л., Кара-теев Д.Е., Балабанова Р.М. Ревматология. Национальное руководство. М.: ГЭОТАР-Медиа; 2008. с. 290-331.
- World Health Organization. The global burden of disease, 2004 Update. http://www.who.int/healthinfo/global_burden_disease/2004_ report_update/en/.
- Балабанова Р.М., Эрдес Ш.Ф. Динамика распространенности ревматических заболеваний, входящих в XIII класс МКБ-10, в популяции взрослого населения Российской Федерации за 20002010 гг. Научно-практическая ревматология 2012; 52(3): 10-2.
- Da Silva E., Doran M.F., Crowson C.S. et al. Declining use of orthopedic surgery in patients with RA? Results of a longterm, population-based assessment. Arthr. Rheum. 2003; 49(2): 216-20.
- Bizzaro N., Tozzoli R., Shoenfeld Y. Are we at a stage to predict autoimmune rheumatic diseases? Arthr. Rheum. 2007; 56(3): 1736-44.
- Vallerskog T., Gunnarsson I., Widhe M. et. al. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin. Immun. 2007; 122: 62-74.
- Bang Н., Egerer K., Gauliard A. et al. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthr. Rheum. 2007; 56: 2503-11.
- Conrad K., Roggenbuck D., Reinhold D. et al. Profiling of rheumatoid arthritis associated autoantibodies. Autoimmun. Rev. 2010; 9: 431-35.
- Kinloch A., Tatzer V., Wait R. et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res. Ther. 2005; 7: 1421-9.
- Song Y.W., Kang E.H. Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. QJM 2010; 103: 139-46.
- Aletaha D., Neogi T., Silman A. et al. 2010 rheumatoid arthritis classification criteria. Arthr. Rheum. 2010; 62(9): 2569-81. 1 2. Shmerling R.H., Delbanco T.L. The rheumatoid factor: an analysis of clinical utility. Am. J. Med. 1991; 91: 528-34.
- Shmerling R.H., Delbanco T.L. How useful is the rheumatoid factor? An analysis of sensitivity, specificity, and predictive value. Arch. Intern. Med. 1992; 152: 2417.
- van Leeuwen M.A., Westra J., van Riel P.L. et al. IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand. J. Rheumatol. 1 995; 24: 146-53. 1 5. van Boekel M.A., Vossenaar E.R., Hoogen F.H. et al. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 2002; 4: 87-93.
- Houssien D.A., Jonsson T., Davies E. et al. Clinical significanse of IgA rheumatoid factor subclasses in rheumatoid arthritis. J. Rheumatol. 1997; 24: 2119-22.
- Новиков А.А., Александрова Е.Н., Черкасова М.В. и др. Современные методы лабораторной диагностики ревматоидного артрита. Научно-практическая ревматология 2010; 1: 31-45.
- Block D.R., Jenkins S.M., Dalenberg D.A. et al. Analytical and clinical comparison of anti-CCP assays with rheumatoid factor for the diagnosis of rheumatoid arthritis. Clin. Chim. Act. 2012; 413(11): 1015-7. 1 9. Koivula M.K., Heliovaara M., Rissanen H. et al. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis. Ann. Rheum. Dis. 2012; 14: 23-7.
- Aggarwal A., Nair R. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthr. Rheum. 2009; 61: 1472-83.
- van Beers J.J., van Venrooij W.J., Pruijn G.J. Two major classes of rheumatoid arthritis: CCP distinguishes between ACPA-positive and ACPA-negative RA. In: Conrad K., Chan E.K., Fritzler M.J. et al., editors. From pathogenesis to therapy of autoimmune diseases: autoantigens, autoantibodies, autoimmunity. Proceedings of the 9th Dresden Symposium on Autoantibodies; 2009 Sep 2-5; Dresden; 2009. p. 265-78.
- Bang H., Luthke K., Gauliard A. et al. Mutadetcitrullinated vimentin (MCV) as a candidate autoantigen for diagnosis and monitoring of disease activity in rheumatoid arthritis. Ann. Rheum. Dis. 2006; 65 Suppl 11: 144.
- Dejaco C., Klotz V., Larcher H. et al. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res. Ther. 2006; 8(4): 119-125.
- Mathsson L., Mullazehi M., Wick M.C. et al. Antibodies against citrullinated vimentin in rheumatoid arthritis. Arthritis & Rheumatism 2008; 58: 36-45.
- Luime J.J., Colin E.M., Hazes J.M. et al. Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review. Ann. Rheum. Dis. 2010; 69: 337-44.
- Combe B., Landewe R., Lukas C. et al. EULAR recommendations for themanagement of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 2007; 66(1): 34-45.
- Braverman L. Disease of the thyroid. Totowa, New Jersey, USA: Human Press; 2003.
- Dayan C.M., Daniels G.H. Chronic autoimmune thyroiditis. N. Eng. J. Med. 1996; 335(2): 99-107.
- Andonopoulos A.P., Siambi V., Makri M. et al. Thyroid function and immune profile in rheumatoid arthritis. A controlled study. Clin. Rheum. 1996; 15(6): 599-603.
- Hijmans W., Doniach D., Roitt I.M. et al. Serological overlap between lupus erythematosus, rheumatoid arthritisand thyroid auto-immune disease. British Medical Journal 1961; 5257(2): 909-14.
- Becker K., Ferguson R., McConahey W. The connective-tissue diseases and symptoms associated with Hashimoto's thyroiditis. N. Eng. J. Med. 1963; 268: 277-80.
- Punzi L., Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 2004; 71(4): 275-83.
- Chistiakov D.A., Turakulov R.I. CTLA-4 and its role in autoimmune thyroid disease. J. Mol. Endocrinol. 2003; 31(1): 21-36.
- Один В.И., Дворовкин А.Э., Колюбаева С.Н. и др. Цитогенетические нарушения у больных ревматоидным артритом, ассоциированным с аутоиммунным тиреоидитом. Биомедицинский журнал 2015; 16: 826-33.
Қосымша файлдар
![](/img/style/loading.gif)